This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.15.21

Cannabis

• South Dakota: Republican Governor Officially Backing Litigation to Reject Voter-Approved Marijuana Legalization Initiative (NORML)

• Montana Lawmakers Reject Funding To Implement Voter-Approved Marijuana Legalization Program (Marijuana Moment)

• Mississippi: Medical Organizations Join Legal Fight to Overturn Election Result Legalizing Medical Cannabis Access (NORML)

• Amsterdam doubles down on plans to restrict tourist access to cannabis coffee shops (CNN)

• New Jersey Is ‘On The Verge’ Of Implementing Marijuana Legalization, Governor Says In State Of The State Speech (Marijuana Moment)

• Mexico releases long-awaited medical cannabis regulations (Marijuana Business Daily)

• Activists Give Out Free Marijuana To Encourage COVID Vaccination With ‘Joints For Jabs’ Campaign (Marijuana Moment)

• USDA Releases Final Rule For Hemp, Two Years After Crop Was Federally Legalized (Marijuana Moment)

• UK grants second only licence to grow medical marijuana (Financial Times)

• Virginia Governor Unveils Bill To Legalize Marijuana As Lawmakers Schedule First Hearing (Marijuana Moment)

• New Mexico Governor Says Marijuana Legalization Is A 2021 Priority (Marijuana Moment)

• Kansas Lawmakers Push To Legalize Medical Marijuana In 2021 (Marijuana Moment)

• Colorado authorities issue recall of contaminated cannabis (Marijuana Business Daily)

• USDA Approves Hemp Regulatory Plans From Rhode Island And Another Indian Tribe (Marijuana Moment)

• The Future of Fully Legal Cannabis (Playboy)

• Top Texas Lawmakers Say Medical Marijuana Expansion Is On The Table For 2021 (Marijuana Moment)

• Survey: Most Americans Say Marijuana Possesses Less Abuse Potential Than Alcohol (NORML)

• North Dakota Activists Submit 2022 Marijuana Legalization Ballot Initiative (Marijuana Moment)

• North Dakota Lawmakers File Bill To Significantly Expand Marijuana Decriminalization Law (Marijuana Moment)

• Legalizing marijuana boosts junk food sales (The Academic Times)

• Medical Marijuana Leads To Reduced Opioid Use, New Study Finds (Marijuana Moment)

• Cannabis dispensaries struggle to find financial support amid pandemic (KRON4)

• FDA Unveils Plan To Fill CBD Research Gaps With ‘Real-World Data’ In 2021 (Marijuana Moment)

• Introducing Mode: The world's first smart cannabis dosing device (KVVU-TV)

• Arizona Prepares To Accept Marijuana Applications Next Week As New Draft Legalization Rules Are Issued (Marijuana Moment)

LSD

• LSD Could Be the Key to Alleviating the Mental Health Crisis—if Government Allows It (Foundation for Economic Education)

• MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers (Psilocybin Alpha)

Magic Mushrooms

• Psychedelic Mushrooms Grew in a Man's Veins After He Injected Them (Gizmodo)

• NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity (Psilocybin Alpha)

• Psilocybin is Being Studied to Help Treat Autism Spectrum Disorder (Baystreet)

• Psilocybin produces an immunology-related genetic response in the prefrontal cortex of pig brains (PsyPost)

• CBDV Begins Research on Psilocybin with Section 56 Exemption from Health Canada (Psilocybin Alpha)

• Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method (AccessWire)

• Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications (GlobeNewswire)

• Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin (Psilocybin Alpha)

MDMA

• Should You Say “I Love You” While on MDMA? (DoubleBlind)

• Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder (Psilocybin Alpha)

Peyote

• Inside a Massive, Illicit Peyote Ceremony During Mexico's COVID Lockdown (VICE)

Iboga

• Ibogaine vs. Iboga Alkaloids for Treating Addiction (Psychedelic Science Review)

Nitrous Oxide

• Police investigation launched after cargo of nitrous oxide canisters discovered in Ribble Valley (Burnley Express)

Ketamine

• A Deadly ‘Ketamine Cocktail’ Is Causing Overdoses on the Streets of Bangkok (VICE)

• Novamind Expands Psychedelic Medicine Access in Utah (Psilocybin Alpha)

Miscellaneous

• Somerville, Massachusetts Decriminalizes Naturally Occurring Psychedelics (DoubleBlind)

• COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care (COMPASS Pathways)

• New York, Virginia And Other States Consider New Drug Decriminalization Bills (Marijuana Moment)

• The World's ‘Largest Illegal Darknet Marketplace’ has Been Shut Down (VICE)

• UFC looks into Johns Hopkins study on psychedelic drugs as potential therapy for fighters (ESPN)

• Michigan Prosecutor Won’t Pursue Most Marijuana Or Psychedelics Cases, ‘Regardless Of The Amount’ (Marijuana Moment)

• DEA Agents Report Agency’s Lack of Basic COVID-19 Safety Measures (Filter)

• When Getting High Is a Hobby, Not a Habit (New York Times)

• How This Black-Led Psychedelic Collective Is Combining Anti-Racism With ‘Sacred Plant Medicine’ (Vogue)

• Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology (Psilocybin Alpha)

• Coping with Antidepressants and Psychedelics (Spirit Pharmacist)

• Psychedelic Illusions are Not Pathological, and May Even Help You See Better (Chacruna)

• Engineering Psychoplastogens: Toward a Safer Alternative for Treating Depression (Psychedelic Science Review)

• Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore (Psilocybin Alpha)

• Revealing Trends in Russia’s Dark-Web Drug Markets (TalkingDrugs)

• Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer (Cision)

• Having A Bad Trip On Psychedelics: Is There Some Value? (Healing Maps)

• The Emerging Revival of Psychedelics in Neuroscience (Psychology Today)

• Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.31.20

Cannabis

• Congress Planning Vote On Federal Marijuana Legalization Bill In September, Sources Say (Marijuana Moment)

• Congress Votes To Protect Legal Marijuana (NORML)

• Democratic Party Delegates Reject Marijuana Legalization Amendment To 2020 Policy Platform (Marijuana Moment)

• Prescribed CBD could help people quit cannabis (Drug Science)

• Louisiana: Medical Cannabis Expansion Laws Take Effect (NORML)

• New York Senate Votes To Expunge Marijuana Convictions For More People (Marijuana Moment)

• New Jersey: Supermajority Back Legalization Measure Ahead of November Vote (NORML)

• Biden Proposes Federal Aid To Help States Expunge Marijuana Records (Marijuana Moment)

• Use of medicines mixed with marijuana allowed in local health promotion hospitals (The Nation Thailand)

• MD Judge: Cops Can’t Search You Because They Smell Weed (Filter)

• THC Microdosing Provides Pain Relief without Psychoactive Effects (Legal Reader)

• Navy Bans Hemp Shampoo For Sailors And Marines As Part Of Broader CBD Prohibition (Marijuana Moment)

• Survey: Many Employees Acknowledge Using Marijuana Immediately Following Their Pre-Employment Drug Test (NORML)

• First woman in Scotland prescribed cannabis legally after years of chronic pain (The Scotsman)

• Women Who Use Marijuana More Often Have Better Sex, Study Says (Marijuana Moment)

• Hedonism and Weed Leads to Happiness (Drug WarRant)

• Cannabis cravings: A new study addresses why it happens (Chicago Tribune)

• Cannabis lowers self reported headaches by nearly 50 percent (Drew Reports News)

LSD

• LSD Chemist William Leonard Pickard to be Released From Prison (Psymposia)

• How LSD is Made (DoubleBlind)

• Was Fleetwood Mac's Peter Green an Acid Casualty? (Celeb Stoner)

Magic Mushrooms

• Man Accused of Selling Mushrooms Faces Up to Twenty Years (Westword)

• Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent (Psilocybin Alpha)

• Palliative Canadians await August 4th decision on psilocybin mushroom approval – TheraPsil urges Health Minister to ‘do the right thing’ (TheraPsil)

• Are magic mushroom edibles Canada’s next drug trend? (The GrowthOp)

• Shroom Expert Duo Releases 2020's First Psilocybin-Focused Cookbook Through Green Candy Press (Newsfile)

Ayahuasca

• Is Ayahuasca Cultural Heritage of Brazil? (Chacruna)

Novel Psychoactive Substances

• MindMed Completes Dosing 18-MC Phase 1 Study (Psilocybin Alpha)

• Crystal Structures of Hydrofumarate Salts of DMT Analogues EPT and MALT Solved (Psychedelic Science Review)

• Solved: The Crystal Structure of the Iodide Salts of DMPT and DMALT (Psychedelic Science Review)

Ketamine

• Ketamine May Help Treat MS-related Fatigue, Small Pilot Trial Suggests (Multiple Sclerosis News Today)

• Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO® (Psilocybin Alpha)

Datura

• Family poisoned in France after mistaking Hell's bells for spinach (CTV News)

Miscellaneous

• DC Officials Count Enough Valid Signatures To Put Psychedelics Decriminalization On Ballot, Activists Say (Marijuana Moment)

• Psychedelic drugs can greatly reduce psychiatric symptoms among special forces veterans, study finds (PsyPost)

• The Business Of Drugs: What Happened To Alexander Shulgin After The DEA Raid (Screen Rant)

• RIP Arnold Trebach, Who Helped Make Opposition to the Drug War Respectable (Reason)

• Empower Clinics Announces the Revocation of Cease Trade Order (Psilocybin Alpha)

• How Set and Setting Shape Psychedelic Cultures (Chacruna)

• Better living through chemistry? The CEO of Dr. Bronner’s wants to turn America on to drugs (Medium)

• The Psychedelic Picture Trip (Maps of the Mind)

• Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S. (Psilocybin Alpha)

• Are there Disadvantages to Microdosing Psychedelics? (DoubleBlind)

• New Psychedelic Online Conferences and Safe Spaces for People of Color (Chacruna)

• Ease restrictions on medical psychedelics to aid research, experts say (The Guardian)

• US Psychiatry Clinics Gear Up For New Psychedelic Treatments (Psilocybin Alpha)

• Entheos Foundation: Amadeus Diamond brings New Zealand psychedelic charity to life (Newshub)

• What It’s Like to Have Sex on Different Kinds of Psychedelics (DoubleBlind)

• Empower Clinics Reports Fiscal 2019 Results (Psilocybin Alpha)

• The Technodelic Augmented Reality of SoundSelf: Interview with Robin Arnott (Psychedelic Times)

• GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences (Psilocybin Alpha)

• Psychedelic Therapy Offers a Synergy of Biological, Psychosocial Interventions (Psychiatry and Behavioral Health Learning Network)

• Founders explain how microdosing on psychedelics has helped them spur new business ideas (Business Insider)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.